S-8 - Lifevantage Corp (0000849146) (Filer)

8-K - Lifevantage Corp (0000849146) (Filer)

8-K - Lifevantage Corp (0000849146) (Filer)

8-K - Lifevantage Corp (0000849146) (Filer)

10-Q - Lifevantage Corp (0000849146) (Filer)

DEFA14A - Lifevantage Corp (0000849146) (Filer)

DEF 14A - Lifevantage Corp (0000849146) (Filer)

S-8 - Lifevantage Corp (0000849146) (Filer)

8-K - Lifevantage Corp (0000849146) (Filer)

10-K - Lifevantage Corp (0000849146) (Filer)

SALT LAKE CITY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024. Mr. Fife and Mr. Aure will meet virtually with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevanta

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. First Quarter Fiscal 2025 Summary*: Revenue of $47.2 million, a decrease of 8.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 7.7%;Revenue in the Americas decreased 4.2%, and revenue in Asia/Pacific & Europe decreased 19.7%. Excluding the negative impact of foreign currency fluctuations, first quarter rev

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. About LifeVantage Corporation LifeVantage Corporation® (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our prod

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leader in health and wellness solutions designed to activate optimal health processes at the cellular level, today announced groundbreaking results from a human clinical trial performed on the new MindBody GLP-1 System™. Results from the trial included a 140% average increase in GLP-1 levels in the body leading to an average weight loss of 9 pounds in 8 weeks and up to 25 pounds in 12 weeks in participants. Ω ‡ Production of GLP-1 (glucagon-like peptide-1) in the body declines due to age, poor diet, stress, or other lifestyle factors. The decline can cause cravings, false hunger, and weight gain. Th

SALT LAKE CITY, Oct. 24, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the LD Micro Main Event XVII, to be held October 28-30, 2024 in Los Angeles, CA. Mr. Fife and Mr. Aure will meet with investors and present at approximately 4:30 p.m. Eastern Time on Wednesday, October 30, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifev

SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours

Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger Hormones and Reduce Cravings, Supporting Sustainable Weight and Visceral Fat Loss While Maintaining Muscle ‡Ω SALT LAKE CITY, Oct. 14, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is excited to announce the U.S. launch of its patent-pending MindBody GLP-1 System™, a dual-product solution designed to balance hunger hormones, build healthier habits, and help individuals reach and maintain their ideal weight. This revolutionary sys

SALT LAKE CITY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced an enhancement to its Evolve Compensation Plan, offering greater simplicity and earning potential for independent LifeVantage Consultants. Plan enhancements are set to go live November 1, 2024, in the U.S., Japan, Australia, New Zealand, Canada, Mexico, and European markets. "When we modernized our compensation plan and launched Evolve in March 2023, it came with the commitment to continuously simplify and enhance the way Consultants earn money at LifeVantage," said

SALT LAKE CITY, Sept. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, has completed its randomized, 12-week human clinical trial evaluating the efficacy of its innovative GLP-1 system for weight management. The study was conducted to explore the system's potential to activate GLP-1 in users and support their health goals. * † The clinical trial, which began in mid-June 2024, involved 60 participants and was designed to assess the impact the innovative two-product system has on weight management, food cravings, and overall well-being, among other fa

SALT LAKE CITY, Sept. 10, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is pleased to announce the promising results of an in vitro study that investigated the combined effects of its upcoming two-product system on activating GLP-1 production.* The study, which began in May and concluded at the end of June 2024, was conducted on specialized L-cells found in the colon, where the body naturally produces GLP-1, a critical hormone in weight management and glucose regulation. Key genes involved in the production and regulation of GLP-1 were thoroughly exam

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

4 - Lifevantage Corp (0000849146) (Issuer)

SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company's Board of Directors effective today. The appointment comes after the Board conducted a comprehensive search to identify a candidate with transformational digital skills and identified Mr. Anbalagan as an exceptional choice. "We are very excited to welcome Rajendran Anbalagan to the LifeVantage Board," said Ray Greer, Chairman. "Raj brings extensive technology experience along with a deep understanding of how to lever

SALT LAKE CITY, July 22, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, will host Open House calls on July 23 and 24, for anyone wanting to learn more about LifeVantage, its activating products, and the Company's industry-leading compensation plan designed to meet modern sharers by supporting both product sellers and team builders. The Open House call on the 23rd will feature a Q&A with LifeVantage President and CEO, Steve Fife, Chief Sales Officer, Kristen Cunningham, and Regional Vice President of Sales, Jake Hines. The discussion will include the e

SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

SALT LAKE CITY, Nov. 27, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes, today announced that the Board of Directors has appointed Raymond Greer as Chairman of the Board. He succeeds Garry Mauro, who will continue to serve as a member of the Board of Directors. "We want to thank Garry for his many contributions while serving as Chairman. He provided critical leadership around our efforts to revamp the management team over the past several years and helped to shape our comprehensive strategic LV360 transformation," said Steve Fife, President an

SALT LAKE CITY, Feb. 17, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) today announced the appointment of Cindy Latham to the Company's Board of Directors. Latham is a senior-level marketing executive with over 30 years of experience leading global marketing, research and development, and product teams in direct selling organizations. Garry Mauro, Chairman, said of the appointment: "We are delighted to welcome Cindy to the LifeVantage Board. She is a proven leader with outstanding industry experience and a strong track record of driving growth." "It's an honor to join the Board at this time, to help shape new strategies and tactics that leverage the incredible power

SALT LAKE CITY, Oct. 25, 2021 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) today announced the appointment of Carl Aure as Chief Financial Officer. Mr. Aure brings more than 24 years of finance and accounting experience including over 15 years in the direct selling industry. He will join the Company on October 25, 2021. "We are pleased to welcome Carl to the LifeVantage team. His deep financial expertise along with an extensive background in direct selling and international operations make him the ideal candidate to lead all aspects of finance, accounting, tax and treasury," said Steve Fife, President and Chief Executive Officer of LifeVantage. "Carl is also a proven leader w

SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that its Board of Directors has named Steven Fife as President and Chief Executive Officer. Mr. Fife’s appointment is effective immediately as he has been serving as Interim Chief Executive Officer since September, 2020. He also joins the Board of Directors. “Steve is a highly experienced and accomplished executive with a deep understanding of our business and a clear vision for the future,” said Garry Mauro, the Company’s Chairman of the Board. Mauro continued, “Steve has been instrumental in the growth and success of the Company since joining as CFO in 2017. As we conducted our sear

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. First Quarter Fiscal 2025 Summary*: Revenue of $47.2 million, a decrease of 8.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 7.7%;Revenue in the Americas decreased 4.2%, and revenue in Asia/Pacific & Europe decreased 19.7%. Excluding the negative impact of foreign currency fluctuations, first quarter rev

SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. About LifeVantage Corporation LifeVantage Corporation® (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our prod

SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours

SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid September 17, 2024 to all stockholders of record at the close of business on September 9, 2024. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company en

SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2024. Fourth Quarter Fiscal 2024 Summary*: Revenue of $48.9 million, a decrease of 9.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was down approximately 8.0%;Revenue in the Americas decreased 4.1% and revenue in Asia/Pacific & Europe decreased 25.2%. Excluding the negative impact of foreign currency fluctuations, fourth

SALT LAKE CITY, Aug. 14, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2024, after the stock market closes on Wednesday, August 28, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approx

SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid June 14, 2024 to all stockholders of record at the close of business on May 31, 2024. This represents an increase in the dividend amount by 14.3% over the previous quarter. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally o

SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: Revenue of $48.2 million, a decrease of 10.2% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was down approximately 8.7%;Revenue in the Americas decreased 5.9%, and revenue in Asia/Pacific & Europe decreased 22.4%. Excluding the negative impact of foreign currency fluctuations, third quarter revenue

SALT LAKE CITY, April 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2024, after the stock market closes on Thursday, May 2, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after t

SALT LAKE CITY, March 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, proudly celebrated Consultant success at Momentum Academy 2024 from March 14-16 at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee. The event was a significant milestone in the Company's commitment to growth, embodying the 'Rise Up' theme and showcasing the U.S. launch of a revamped TrueScience® Activated Skincare Collection as well as the introduction of TrueScience® TrueProtect Daily Mineral Sunstick, a broad-spectrum, mineral-based, sheer sunscreen. LifeVantage Pre

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.16 by 31.25 percent. This is a 162.5 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $48.245 million which missed the analyst consensus estimate of $52.182 million by 7.54 percent. This is a 10.23 percent decrease over sales of $53.741 million the same period last year.

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, is proud to announce the launch of its TrueScience® Activated Skin Care Collection, marking a significant advancement in skincare technology and formulation. Building on the successful October 2023 launch of TrueRenew Daily Firming Complex, a better-than-retinol alternative, LifeVantage's entire skincare offering has been enhanced to provide skin health activation in every step. The Collection delivers a simple regimen of multi-tasking products that meet the sophisticated needs of today's busy consumers. The products were first revealed March 2

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, proudly announces the successful expansion of LV360 into Canada, Mexico, and its European markets including the UK, Ireland, Germany, Austria, Belgium, Spain, and the Netherlands. The Company's Evolve Compensation Plan and Rewards Circle customer loyalty program went into effect February 1 in these markets after a successful launch in the U.S., Australia, New Zealand, and Japan, in March of last year."LV360 is the answer to the evolving direct sales industry. We strategically decided to not shy away from the need to change and committ

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.04 by 150 percent. This is a 242.86 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $51.62 million which missed the analyst consensus estimate of $54.65 million by 5.54 percent. This is a 3.80 percent decrease over sales of $53.66 million the same period last year.

Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million. • Hubbell (NYSE:HUBB) is expected to report quarterly earnings at $3.57 per share on revenue of $1.32 billion. • ManpowerGroup (NYSE:MAN) is estimated to report quarterly earnings at $1.20 per share on revenue of $4.56 billion. • Corning (NYSE:GLW) is likely to report quarterly earnings at $0.39 per share on revenue of $3.25 billion. • Cambridge (NASDAQ:CATC) is estimated to report quarterly earnings at $0.93 per share on revenue of $38.38 million. • Malibu Boats (NASDAQ:MBUU) is likely to report quarterly earnings at $0.48 pe

Lifevantage (NASDAQ:LFVN) is set to give its latest quarterly earnings report on Tuesday, 2024-01-30. Here's what investors need to know before the announcement. Analysts estimate that Lifevantage will report an earnings per share (EPS) of $0.04. Lifevantage bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Here's a look at Lifevantage's past performance and the resulting price change: Quarter Q1 2024 Q4 2023 Q3 2023 Q2 2023

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today announced that Company scientists have completed a study on the impact Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen have on cellular health. The study results showed that when combined, the products work together to help cells accurately respond to stress levels and recover more quickly, supporting the body's immune function. "When cells are stressed they send out signals asking for help from the immune system," explained Lisa Barnes, Vice President of Research & Development. "However, even after the stressor is eliminated, it can be

Gainers Bruush Oral Care (NASDAQ:BRSH) stock increased by 25.6% to $0.2 during Friday's regular session. As of 12:31 EST, Bruush Oral Care's stock is trading at a volume of 1.1 million, which is 77.0% of its average full-day volume over the last 100 days. Natural Grocers (NYSE:NGVC) shares increased by 20.62% to $15.44. As of 12:31 EST, this security is trading at a volume of 117.0K shares, making up 375.5% of its average full-day volume over the last 100 days. The company's market cap stands at $351.0 million. As per the news, the Q4 earnings report came out yesterday. Beauty Health (NASDAQ:SKIN) stock moved upwards by 17.41% to $2.09. Trading volume for Beauty Health's stock is 6.3 mill